27.09.2021 22:31

Kleiner Device Labs to Showcase New KG2 Surge Flow-Thru Interbody System at NASS


INCLINE VILLAGE, Nev., Sept. 27, 2021 /PRNewswire/ -- Kleiner Device Labs today announced that at the upcoming NASS conference in Boston it will be showcasing the new KG2 Surge flow-thru interbody system that recently received U.S. Food and Drug Administration (FDA) 510(k) market clearance.  The company will have the KG2 Surge system for surgeons to handle and test with simulated graft material, and will share the experiences of surgeons who tested the device in cadaver labs.

Kleiner Device Labs' KG(TM)2 Surge(TM) flow-thru interbody system maximizes total bone graft delivery volume and better distributes graft bilaterally into the intervertebral disc space for TLIF and PLIF spinal fusion procedures.

The new KG2 Surge flow-thru interbody system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning and grafting process for TLIF and PLIF spinal fusion procedures.  The implant comes preassembled to the inserter in a single-patient-use tray.

"This will be the first conference for surgeons and allograft suppliers to test production-grade samples of this exciting new system for TLIF and PLIF spinal fusion procedures," said Jeff Kleiner, MD, founder and CEO of Kleiner Device Labs. 

NASS attendees will be able to find the company at booth 2345 on the main aisle of the exhibition floor.  "Look for the big yellow flow-thru road sign at the corner of our booth," added Mike Hughes, the company's Chief Commercial Officer.

NASS, the North American Spine Society's annual conference, begins Wednesday, September 29 in the Boston Convention and Exhibition Center.

The company will next launch the product with a select group of surgeons and will be building inventory for its full commercial launch.

A short video demonstrating how the KG2 Surge flow-thru interbody system works is available here.

About Kleiner Device Labs
Kleiner Device Labs is creating new instruments and devices to advance minimally invasive spine surgery and improve outcomes and costs for patients, surgeons, hospitals and payers.  Kleiner Device Labs is headquartered in Incline Village, Nevada.  More information is available on the company's web site at http://www.kleinerlabs.com/.  

KG and Surge are trademarks of Kleiner Device Labs.

MKT-00010-25 Rev 1

Sales and Surgeon Contact:
Mike Hughes
M: 949.632.0769

Media Contact:
Brad Samson                          
M: 714.955.3951

Investor Contact:
Stewart Peabody
M: 312.498.5892

Kleiner Device Labs Logo (PRNewsfoto/Kleiner Device Labs)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kleiner-device-labs-to-showcase-new-kg2-surge-flow-thru-interbody-system-at-nass-301385990.html

SOURCE Kleiner Device Labs

Börse Stuttgart Anlegerclub

Heute im Fokus

DAX fester -- Ceconomy kommt unter Druck -- KION sieht sich nach starkem Quartal auf Kurs bei Jahreszielen -- EVOTEC, Siltronic, Symrise,UBS, Facebook im Fokus

HeidelbergCement verstärkt Geschäft in Tansania. Chinas Immobilienkonzern Modern Land in Zahlungsverzug. Hyundai verfehlt Erwartungen. BASF-Mehrheitsbeteiligung Wintershall Dea mit Gewinnsprung. Reckitt Benckiser hebt Umsatzprognose für Gesamtjahr an. Orange mit Erlösrückgang. Pfeiffer Vacuum hebt Ausblick weiter an. Volkswagens US-Lkw-Tochter Navistar zahlt Millionen in Abgasvergleich. Vonovia hält nach Ende des Übernahmeangebots 87,6 Prozent an Deutsche Wohnen.


Würden Sie eine verpflichtende Corona-Impfung gutheißen?

finanzen.net zero
finanzen.net zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln